Abvc Biopharma Stock Price on December 11, 2024
| ABVC Stock | USD 0.86 0.06 7.50% |
Below is the normalized historical share price chart for ABVC Biopharma extending back to November 10, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ABVC Biopharma stands at 0.86, as last reported on the 30th of March, with the highest price reaching 0.87 and the lowest price hitting 0.79 during the day.
If you're considering investing in ABVC Stock, it is important to understand the factors that can impact its price. ABVC Biopharma appears to be extremely dangerous, given 3 months investment horizon. ABVC Biopharma secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of volatility over the last 3 months. By reviewing ABVC Biopharma's technical indicators, you can evaluate if the expected return of 0.78% is justified by implied risk. Please makes use of ABVC Biopharma's Market Risk Adjusted Performance of (0.70), coefficient of variation of 634.9, and Mean Deviation of 4.23 to double-check if our risk estimates are consistent with your expectations.
At present, ABVC Biopharma's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 17.5 M, whereas Common Stock is forecasted to decline to 8,674. . As of March 30, 2025, Price To Sales Ratio is expected to decline to 36.05. In addition to that, Price Earnings Ratio is expected to decline to -0.45. ABVC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of October 2017 | 200 Day MA 0.6368 | 50 Day MA 0.6026 | Beta 0.67 |
ABVC |
Sharpe Ratio = 0.1308
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ABVC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.99 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.78 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average ABVC Biopharma is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABVC Biopharma by adding it to a well-diversified portfolio.
Price Book 2.4377 | Enterprise Value Ebitda (1.90) | Price Sales 39.9687 | Shares Float 9.4 M | Wall Street Target Price 2.02 |
Related Headline
Indaptus Therapeutics Headline on 11th of December 2024
Acquisition by Hayes William B of 12500 shares of Indaptus T... by Hayes William B
Filed transaction by Indaptus Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
ABVC Biopharma Valuation on December 11, 2024
It is possible to determine the worth of ABVC Biopharma on a given historical date. On December 11, 2024 ABVC was worth 0.45 at the beginning of the trading date compared to the closed value of 0.52. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ABVC Biopharma stock. Still, in general, we apply an absolute valuation method to find ABVC Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ABVC Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ABVC Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.49 | 0.50 | 0.47 | 0.47 | 186,629 | |
12/11/2024 | 0.45 | 0.52 | 0.42 | 0.52 | 5,319,676 |
| 0.52 | 0.52 | 0.47 | 0.52 | 343,742 |
| Backtest ABVC Biopharma | | | ABVC Biopharma History | | | ABVC Biopharma Valuation | Previous | Next |
ABVC Biopharma Trading Date Momentum on December 11, 2024
| On December 12 2024 ABVC Biopharma was traded for 0.52 at the closing time. The top price for the day was 0.52 and the lowest listed price was 0.47 . The trading volume for the day was 343.7 K. The trading history from December 12, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.92% . |
ABVC Biopharma Fundamentals Correlations and Trends
By evaluating ABVC Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ABVC Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ABVC financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ABVC Biopharma Stock history
ABVC Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ABVC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ABVC Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ABVC Biopharma stock prices may prove useful in developing a viable investing in ABVC Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.9 M | 4.1 M | |
| Net Loss | -14.8 M | -14 M |
ABVC Biopharma Stock Technical Analysis
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ABVC Biopharma Period Price Range
Low | March 30, 2025
| High |
0.00 | 0.00 |
ABVC Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ABVC Biopharma March 30, 2025 Market Strength
Market strength indicators help investors to evaluate how ABVC Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ABVC Biopharma shares will generate the highest return on investment. By undertsting and applying ABVC Biopharma stock market strength indicators, traders can identify ABVC Biopharma entry and exit signals to maximize returns
ABVC Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ABVC Biopharma's price direction in advance. Along with the technical and fundamental analysis of ABVC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ABVC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1437 | |||
| Jensen Alpha | 0.8563 | |||
| Total Risk Alpha | 1.3 | |||
| Sortino Ratio | 0.1608 | |||
| Treynor Ratio | (0.71) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |